Results 241 to 250 of about 3,949,650 (302)
Some of the next articles are maybe not open access.

Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents.

ACS Chemical Neuroscience, 2018
Sabine Mogwitz   +3 more
semanticscholar   +1 more source

Vestibular compensation is affected by treatment with dopamine active agents.

Archives italiennes de biologie, 1993
The aim of the present work was to examine the effects of postoperative treatments with agents active on dopaminergic system on vestibular recovery from the postural and ocular symptoms which follow a unilateral labyrinthectomy. Hemilabyrinthectomized guinea pigs were given a daily i.p.
PETROSINI, Laura, M. E. Dell'Anna
openaire   +2 more sources

Effect of dopamine agents on schedule- and deprivation-induced drinking in rats.

Pharmacology, Biochemistry and Behavior, 1987
S. Snodgrass, J. Allen
semanticscholar   +1 more source

Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157.

Journal of Physiology - Paris, 2000
P. Sikiric   +22 more
semanticscholar   +1 more source

Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy.

ACS Applied Materials and Interfaces, 2015
Da Zhang   +7 more
semanticscholar   +1 more source

Dopamine D3 receptor agents in schizophrenia

European Neuropsychopharmacology, 1999
P. Sokoloff   +3 more
openaire   +1 more source

Dopamine agents for the treatment of the negative symptoms of schizophrenia

, 1995
R. Buchanan   +4 more
semanticscholar   +1 more source

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Pharmacological Reviews, 2011
J. Beaulieu, R. Gainetdinov
semanticscholar   +1 more source

Development of imaging agents for the dopamine transporter

Medicinal Research Reviews, 1995
F I, Carroll   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy